- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 15:58 | Obesity needs a new clinical definition, study finds | ||
| 14:59 | Google Cloud launches Gemini for Healthcare | ||
| 13:58 | UK's Levicept builds case for osteoarthritis therapy at ACR | ||
| 12:58 | AZ boosts vaccine capabilities with Omniose buy | ||
| 11:58 | Merck's rare tumour drug Pimjetmi claims FDA approval | ||
| Di | Third Rock in $2bn drug-hunting pact with China's Funnel | ||
| Di | UK's Oyster Tx rebrands and raises $60m for Alzheimer's R&D | ||
| Di | Hims & Hers to offer unapproved peptides to customers | ||
| Di | FDA orders blindness risk warning to GLP-1 agonist labels | ||
| Di | Bayer bags FDA green light for stroke drug Sunharbo | ||
| Mo | Amazon puts $100m into global health drive | ||
| Mo | MHRA grants Innovation Passports to three novel drugs | ||
| Mo | argenx agrees Unnatural takeover deal worth up to $1.15bn | ||
| Mo | Moderna to relocate its UK HQ to London's Tribeca | ||
| Mo | Novartis' pelacarsen fail raises questions for other drugs | ||
| Fr | Lilly partners with Hims & Hers on obesity drug sales | ||
| Fr | Inflammation-focused Rezera sets terms for IPO | ||
| Fr | Moderna, Oxford Uni Ebola jabs backed for pivotal testing | ||
| Fr | UK pilots shorter NICE appraisal for new medicines | ||
| Fr | J&J's Rybrevant Faspro moves beyond lung cancer with FDA nod | ||
| Do | UK backs start-up Potential Sciences' AI-powered drug hunt | ||
| Do | UK backs startup Potential Sciences' AI-powered drug hunt | ||
| Do | Bayer's Hyrnuo moves first-line for lung cancer in China | ||
| Do | UK biotechs T-Therapeutics and Alethio score big financings | ||
| Do | NICE backs Keytruda/Padcev combo for bladder cancer |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.